Company News
07 May 2025
Lumos CEO and MD, Doug Ward, and CFO, Barrie Lambert, this week presented the Company's Q3 FY25 quarterly results. The presentation covers recent achievements including an update on the FebriDx CLIA Waiver study, strategic partnership agreements, and key priorities for the next quarter.
Take a look:
A few more pieces along the same thread. See the full index for everything.
COMPANY NEWS
1 min read
MST Access has published a research report on Lumos Diagnostics Limited.
COMPANY NEWS
2 min read
Lumos Diagnostics has announced further progress in the U.S. commercialisation of FebriDx® across its priority top-100 urgent care target list.
COMPANY NEWS
1 min read
Lumos CEO Doug Ward, Lumos Chief Commercial Officer Paul Kase, Lumos Director of U.S. Sales